Last reviewed · How we verify
BITR2101
At a glance
| Generic name | BITR2101 |
|---|
| Sponsor | Boston Immune Technologies and Therapeutics |
|---|
| Modality | Biologic |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.